Drug intelligence / Profile preview

Immubiotic Family

Development stage: Unknown
Lead developer: Ceres Pharma
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Immubiotic Family is a probiotic dietary supplement developed by Vesale Pharma, designed to support the immune system in both pediatric and adult populations. The formulation consists of four specific probiotic strains—*Lactobacillus rhamnosus*, *Lactobacillus casei*, *Lactobacillus acidophilus*, and *Lactobacillus johnsonii*—combined with Vitamin C (ascorbic acid). A key feature of the product is the use of Intelicaps®, a patented microencapsulation technology that protects the probiotic bacteria from gastric acidity and environmental degradation, ensuring optimal delivery and colonization in the intestinal tract. Available as strawberry-flavored chewable tablets, it is positioned for daily use to maintain a healthy gut microbiota and strengthen natural defenses.

Brand names: Immubiotic Family

Beyond the preview

Go deeper on Immubiotic Family.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immubiotic Family.

Explore the full profile